Company Profile
Beijing Fukangren Bio-Pharm Tech Co., Ltd. is an innovative chemical company based in Daxing District, Beijing, China. Established in 2010, the company's mission is to provide high-quality chemical products and services to customers in the pharmaceutical, healthcare, and life science industries.
The company is renowned for its expertise in the development and manufacturing of complex chemical compounds and intermediates. Its product range includes organic chemicals, inorganic chemicals, and biochemicals, which are utilized in various applications such as pharmaceutical research, diagnostic kits, and biotechnology.
In addition to its manufacturing capabilities, Beijing Fukangren Bio-Pharm Tech Co., Ltd. also offers a comprehensive range of analytical and testing services to ensure the quality and purity of its products. The company's state-of-the-art laboratory facilities are equipped with cutting-edge equipment and techniques to perform various analytical tests, including UV-Vis, HPLC, and GC analysis.
The company's commitment to environmental sustainability and social responsibility is reflected in its manufacturing processes, which are designed to minimize waste and pollution. Beijing Fukangren Bio-Pharm Tech Co., Ltd. also adheres to strict quality control and safety protocols, and is dedicated to ethical business practices and customer satisfaction.
VIEW MORE VIEW LESS
Product List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
Argatroban |
Argatroban (hydrate);Argatroban (2R,4R)-1-[(2S)-5-[(Aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid;Argatroban (350 mg);(2R,4R)-1-[(2S)-5-[(Aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid hydrate;(2r,4r)-4-methyl-1-[n-[(3-methyl-1,2,3,4-tetrahydro-8-quinolinyl)sulfonyl]-l-arginyl]-2-piperidinecarboxylic acid;(2r,4r)-1-[(2s)-5-[(aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-piperidinecarboxylic acid;GN1600;(2R,4R)-1-[N2-3-(methyl-1,2,3,4-tetrahydro-8-quinolinesulfonyl)-L-arginyl]-4-methyl-2-piperidinecarboxylic acid monohydrate |
141396-28-3 | - / 99.5% | Inquiry |
Canagliflozin hemihydrate |
928672-86-0 | - / 99.5% | Inquiry | |
Cevimeline |
Spiro[1-azabicyclo[2.2.2]octane-3,5′-[1,3]oxathiolane],2′-methyl-,(2′R,3R)-rel-;Spiro[1-azabicyclo[2.2.2]octane-3,5′-[1,3]oxathiolane],2′-methyl-,cis-;rel-(2′R,3R)-2′-Methylspiro[1-azabicyclo[2.2.2]octane-3,5′-[1,3]oxathiolane];(±)-cis-2-Methylspiro[1,3-oxathiolane-5,3′-quinuclidine];Cevimeline;cis-2-Methylspiro[1,3-oxathiolane-5,3′-quinuclidine] |
107233-08-9 | - / 99.5% | Inquiry |
Dapagliflozin propylene glycolate hydrate |
D-Glucitol,1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-,(1S)-,compd. with (2S)-1,2-propanediol,hydrate (1:1:1);D-Glucitol,1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-,(1S)-,compd. with (2S)-1,2-propanediol (1:1),monohydrate;(1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol (S)-propane-1,2-diol (1:1) monohydrate;Dapagliflozin (S)-propylene glycol hydrate;Edistride;Farxiga;Dapagliflozin propanediol monohydrate;Forxiga |
960404-48-2 | - / 99.5% | Inquiry |
Glycopyrronium Bromide |
Pyrrolidinium,3-[[(2R)-2-cyclopentyl-2-hydroxy-2-phenylacetyl]oxy]-1,1-dimethyl-,bromide (1:1),(3S)-rel-;Pyrrolidinium,3-[(cyclopentylhydroxyphenylacetyl)oxy]-1,1-dimethyl-,bromide,(R*,S*)-(±)-;Pyrrolidinium,3-[[(2R)-cyclopentylhydroxyphenylacetyl]oxy]-1,1-dimethyl-,bromide,(3S)-rel-;erythro-Glycopyrronium bromide;Ritropirronium bromide;erythro-3-Hydroxy-1,1-dimethylpyrrolidinium bromide α-cyclopentylmandelate;59677-71-3 |
51186-83-5 | - / 99.5% | Inquiry |
Nilvadipine |
3,5-Pyridinedicarboxylic acid,2-cyano-1,4-dihydro-6-methyl-4-(3-nitrophenyl)-,3-methyl 5-(1-methylethyl) ester;FR 34235;FK 235;Nilvadipine;(±)-Nilvadipine;dl-Nilvadipine;Nivadil;SKF 102362;Escor;Nivaldipine;CL 287389;Nivadip;3-O-Methyl 5-O-propan-2-yl 2-cyano-6-methyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;111102-35-3 |
75530-68-6 | - / 99.5% | Inquiry |
Ramatroban |
9H-Carbazole-9-propanoic acid,3-[[(4-fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-,(3R)-;9H-Carbazole-9-propanoic acid,3-[[(4-fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-,(R)-;(3R)-3-[[(4-Fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9H-carbazole-9-propanoic acid;BAY-u 3405;Ramatroban;Baynas;3-[(3R)-3-[(4-Fluorophenyl)sulfonylamino]-1,2,3,4-tetrahydrocarbazol-9-yl]propanoic acid |
116649-85-5 | - / 99.5% | Inquiry |
Solifenacin succinate |
Butanedioic acid,compd. with (1S)-(3R)-1-azabicyclo[2.2.2]oct-3-yl 3,4-dihydro-1-phenyl-2(1H)-isoquinolinecarboxylate (1:1);2(1H)-Isoquinolinecarboxylic acid,3,4-dihydro-1-phenyl-,(3R)-1-azabicyclo[2.2.2]oct-3-yl ester,(1S)-,butanedioate (1:1);Solifenacin succinate;Vesicare;Vesikur;YM 67905 |
242478-38-2 | - / 99.5% | Inquiry |